{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:23:48Z","timestamp":1777307028146,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Idiopathic pulmonary fibrosis (IPF) may present comorbid obstructive lung diseases with small airway dysfunction (SAD). Existing guidelines suggest that inhaled bronchodilators should be used if the ratio of forced expiratory volume in the 1st second and forced vital capacity (FEV<jats:sub>1<\/jats:sub>\/FVC)\u2009&lt;\u20090.7 in IPF. However, most IPF patients have FEV<jats:sub>1<\/jats:sub>\/FVC\u2009&gt;\u20090.7 even with coexisting emphysema. We retrospectively enrolled IPF patients who were registered at our outpatient clinic. At baseline, 63 patients completed computed tomography (CT) scans, lung function measurements, and symptom questionnaires. Among these patients, 54 (85.71%) underwent antifibrotic treatment and 38 (60.32%) underwent long-acting bronchodilator treatment. The median FEV<jats:sub>1<\/jats:sub>\/FVC was 0.86. Not all patients treated with bronchodilators showed significant changes in lung function. IPF patients with SAD, determined by IOS parameters, showed significant improvement in FEV<jats:sub>1<\/jats:sub>, FEF<jats:sub>25\u201375%<\/jats:sub>, and symptom scores after bronchodilator treatment. Bronchodilator efficacy was not observed in patients without SAD. CT-confirmed emphysema was seen in 34.92% of patients. There were no changes in lung function or symptom scores after bronchodilator treatment in patients with emphysema. In conclusion, FEV<jats:sub>1<\/jats:sub>\/FVC cannot reflect the airflow limitation in IPF. Emphysema in IPF is not a deciding factor in whether patients should receive bronchodilator treatment. IOS parameters may be useful to guide bronchodilator therapy in patients with IPF coexisting with SAD.<\/jats:p>","DOI":"10.1038\/s41598-020-75597-2","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T11:02:54Z","timestamp":1603969374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Functional parameters of small airways can guide bronchodilator use in idiopathic pulmonary fibrosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Po-Wei","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Kuo","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Cheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Yih","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Juin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Han","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diahn-Warng","family":"Perng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"key":"75597_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis, W. D. et al. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 188, 733\u2013748 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"75597_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1183\/09059180.00003214","volume":"24","author":"G Bagnato","year":"2015","unstructured":"Bagnato, G. & Harari, S. Cellular interactions in the pathogenesis of interstitial lung diseases. Eur. Respir. Rev. 24, 102\u2013114 (2015).","journal-title":"Eur. Respir. Rev."},{"key":"75597_CR3","doi-asserted-by":"crossref","unstructured":"Raghu, G.\u00a0et al.\u00a0Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline.\u00a0Am. J. Respir. Crit. Care Med.\u00a0198, e44\u2013e68 (2018).","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"75597_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu, G. et al. An official ATS\/ERS\/JRS\/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788\u2013824 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"75597_CR5","doi-asserted-by":"crossref","unstructured":"Marshall, D. C., Salciccioli, J. D., Shea, B. S. & Akuthota, P. Trends in mortality from idiopathic pulmonary fibrosis in the European Union: An observational study of the WHO mortality database from 2001\u20132013.\u00a0Eur. Respir. J.\u00a051 (2018).","DOI":"10.1183\/13993003.01603-2017"},{"key":"75597_CR6","doi-asserted-by":"crossref","unstructured":"Plantier, L.\u00a0et al.\u00a0Physiology of the lung in idiopathic pulmonary fibrosis.\u00a0Eur. Respir. Rev.\u00a027 (2018).","DOI":"10.1183\/16000617.0062-2017"},{"key":"75597_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","volume":"46","author":"G Raghu","year":"2015","unstructured":"Raghu, G., Amatto, V. C., Behr, J. & Stowasser, S. Comorbidities in idiopathic pulmonary fibrosis patients: A systematic literature review. Eur. Respir. J. 46, 1113\u20131130 (2015).","journal-title":"Eur. Respir. J."},{"key":"75597_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12890-015-0084-1","volume":"15","author":"J Pastre","year":"2015","unstructured":"Pastre, J. et al. Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases. BMC Pulm. Med. 15, 100 (2015).","journal-title":"BMC Pulm. Med."},{"key":"75597_CR9","unstructured":"2020 Global Strategy for Prevention, Diagnosis and Management of COPD. https:\/\/goldcopd.Org\/gold-reports\/. Accessed 10 Mar 2020."},{"key":"75597_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1183\/09059180.00001814","volume":"23","author":"V Cottin","year":"2014","unstructured":"Cottin, V. et al. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines. Eur. Respir. Rev. 23, 193\u2013214 (2014).","journal-title":"Eur. Respir. Rev."},{"key":"75597_CR11","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.rmed.2015.06.012","volume":"109","author":"D Assayag","year":"2015","unstructured":"Assayag, D. et al. The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis. Respir. Med. 109, 1058\u20131062 (2015).","journal-title":"Respir. Med."},{"key":"75597_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1378\/chest.13-1875","volume":"146","author":"S Bickel","year":"2014","unstructured":"Bickel, S., Popler, J., Lesnick, B. & Eid, N. Impulse oscillometry: Interpretation and practical applications. Chest 146, 841\u2013847 (2014).","journal-title":"Chest"},{"key":"75597_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.anai.2012.06.022","volume":"109","author":"WJ Anderson","year":"2012","unstructured":"Anderson, W. J., Zajda, E. & Lipworth, B. J. Are we overlooking persistent small airways dysfunction in community-managed asthma?. Ann. Allergy Asthma Immunol. 109, 185-189.e2 (2012).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"75597_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000452479","volume":"93","author":"E Crisafulli","year":"2017","unstructured":"Crisafulli, E. et al. Prevalence of small-airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease. Respiration 93, 32\u201341 (2017).","journal-title":"Respiration"},{"key":"75597_CR15","doi-asserted-by":"crossref","unstructured":"Jones, P. W., Quirk, F. H., Baveystock, C. M. & Littlejohns, P. A self-complete measure of health status for chronic airflow limitation: The St. George\u2019s Respiratory Questionnaire.\u00a0Am. Rev. Respir. Dis. 145, 1321\u20131327 (1992).","DOI":"10.1164\/ajrccm\/145.6.1321"},{"key":"75597_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones, P. W. et al. Development and first validation of the COPD assessment test. Eur. Respir. J. 34, 648\u2013654 (2009).","journal-title":"Eur. Respir. J."},{"key":"75597_CR17","doi-asserted-by":"crossref","unstructured":"Furukawa, T.\u00a0et al.\u00a0The St. George\u2019s Respiratory Questionnaire as a prognostic factor in IPF.\u00a0Respir. Res. 18 (2017).","DOI":"10.1186\/s12931-017-0503-3"},{"key":"75597_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12931-017-0621-y","volume":"18","author":"M Kreuter","year":"2017","unstructured":"Kreuter, M. et al. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry. Respir. Res. 18, 139\u2013148 (2017).","journal-title":"Respir. Res."},{"key":"75597_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12931-020-1298-1","volume":"21","author":"M Kreuter","year":"2020","unstructured":"Kreuter, M. et al. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: Analyses of patient-reported outcomes from the INPULSIS trials. Respir. Res. 21, 36\u201347 (2020).","journal-title":"Respir. Res."},{"key":"75597_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/resp.12936","volume":"22","author":"T Matsuda","year":"2017","unstructured":"Matsuda, T. et al. COPD assessment test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study. Respirology 22, 721\u2013727 (2017).","journal-title":"Respirology"},{"key":"75597_CR21","doi-asserted-by":"publisher","first-page":"1530028","DOI":"10.1080\/20018525.2018.1530028","volume":"5","author":"HK Grufstedt","year":"2018","unstructured":"Grufstedt, H. K., Shaker, S. B. & Konradsen, H. Validation of the COPD assessment test (CAT) in patients with idiopathic pulmonary fibrosis. Eur. Clin. Respir. J. 5, 1530028 (2018).","journal-title":"Eur. Clin. Respir. J."},{"key":"75597_CR22","doi-asserted-by":"crossref","unstructured":"Graham, B. L.\u00a0et al.\u00a0Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement.\u00a0Am. J. Respir. Crit. Care Med.\u00a0200, e70\u2013e88 (2019).","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"75597_CR23","doi-asserted-by":"crossref","unstructured":"Graham, B. L.\u00a0et al.\u00a02017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung.\u00a0Eur. Respir. J.\u00a049 (2017).","DOI":"10.1183\/13993003.00016-2016"},{"key":"75597_CR24","doi-asserted-by":"crossref","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test.\u00a0Am. J. Respir. Crit. Care Med.\u00a0166, 111\u2013117 (2002).","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"75597_CR25","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino, R. et al. Interpretative strategies for lung function tests. Eur. Respir. J. 26, 948\u2013968 (2005).","journal-title":"Eur. Respir. J."},{"key":"75597_CR26","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1183\/09031936.03.00089403","volume":"22","author":"E Oostveen","year":"2003","unstructured":"Oostveen, E. et al. The forced oscillation technique in clinical practice: Methodology, recommendations and future developments. Eur. Respir. J. 22, 1026\u20131041 (2003).","journal-title":"Eur. Respir. J."},{"key":"75597_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jaip.2019.06.035","volume":"8","author":"H-Y Chiu","year":"2020","unstructured":"Chiu, H.-Y. et al. Small airway dysfunction by impulse oscillometry in symptomatic patients with preserved pulmonary function. J. Allergy Clin. Immunol. Pract. 8, 229-235.e3 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"75597_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1164\/rccm.200301-053SO","volume":"168","author":"JH Ryu","year":"2003","unstructured":"Ryu, J. H., Myers, J. L. & Swensen, S. J. Bronchiolar disorders. Am. J. Respir. Crit. Care Med. 168, 1277\u20131292 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"75597_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1183\/20734735.020514","volume":"11","author":"B Brashier","year":"2015","unstructured":"Brashier, B. & Salvi, S. Measuring lung function using sound waves: Role of the forced oscillation technique and impulse oscillometry system. Breathe (Sheff) 11, 57\u201365 (2015).","journal-title":"Breathe (Sheff)"},{"key":"75597_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/annurev-physiol-021113-170411","volume":"76","author":"D Morse","year":"2014","unstructured":"Morse, D. & Rosas, I. O. Tobacco smoke-induced lung fibrosis and emphysema. Annu. Rev. Physiol. 76, 493\u2013513 (2014).","journal-title":"Annu. Rev. Physiol."},{"key":"75597_CR31","first-page":"263","volume":"53","author":"A Xaubet","year":"2017","unstructured":"Xaubet, A. et al. Guidelines for the medical treatment of idiopathic pulmonary fibrosis. Arch. Bronconeumol. 53, 263\u2013269 (2017).","journal-title":"Arch. Bronconeumol."},{"key":"75597_CR32","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi, L. et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2071\u20132082 (2014).","journal-title":"N. Engl. J. Med."},{"key":"75597_CR33","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King, T. E. Jr. et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2083\u20132092 (2014).","journal-title":"N. Engl. J. Med."},{"key":"75597_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S2213-2600(14)70103-1","volume":"2","author":"B Lipworth","year":"2014","unstructured":"Lipworth, B., Manoharan, A. & Anderson, W. Unlocking the quiet zone: The small airway asthma phenotype. Lancet Respir. Med. 2, 497\u2013506 (2014).","journal-title":"Lancet Respir. Med."},{"key":"75597_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2466-10-10","volume":"10","author":"A Haruna","year":"2010","unstructured":"Haruna, A. et al. Relationship between peripheral airway function and patient-reported outcomes in COPD: A cross-sectional study. BMC Pulm. Med. 10, 10 (2010).","journal-title":"BMC Pulm. Med."},{"key":"75597_CR36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1378\/chest.116.2.543","volume":"116","author":"P Brand","year":"1999","unstructured":"Brand, P. et al. Aerosol-derived airway morphometry and aerosol bolus dispersion in patients with lung fibrosis and lung emphysema. Chest 116, 543\u2013548 (1999).","journal-title":"Chest"},{"key":"75597_CR37","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.rmed.2013.03.005","volume":"107","author":"A Sugiyama","year":"2013","unstructured":"Sugiyama, A. et al. Characteristics of inspiratory and expiratory reactance in interstitial lung disease. Respir. Med. 107, 875\u2013882 (2013).","journal-title":"Respir. Med."},{"key":"75597_CR38","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.transproceed.2017.12.060","volume":"50","author":"M Ochman","year":"2018","unstructured":"Ochman, M. et al. Usefulness of the impulse oscillometry system in graft function monitoring in lung transplant recipients. Transplant. Proc. 50, 2070\u20132074 (2018).","journal-title":"Transplant. Proc."},{"key":"75597_CR39","doi-asserted-by":"crossref","unstructured":"Guerrero Z\u00fa\u00f1iga, S.\u00a0et al.\u00a0Small airway dysfunction in chronic hypersensitivity pneumonitis.\u00a0Respirology\u00a022, 1637\u20131642 (2017).","DOI":"10.1111\/resp.13124"},{"key":"75597_CR40","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.jaip.2019.04.019","volume":"7","author":"PW Sullivan","year":"2019","unstructured":"Sullivan, P. W., Ghushchyan, V. H., Marvel, J., Barrett, Y. C. & Fuhlbrigge, A. L. Association between pulmonary function and asthma symptoms. J. Allergy Clin. Immunol. Pract. 7, 2319\u20132325 (2019).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"75597_CR41","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/resp.13030","volume":"22","author":"S Canu","year":"2017","unstructured":"Canu, S., Alfieri, V. & Renzoni, E. Patient-reported outcome measures in idiopathic pulmonary fibrosis: Where do we stand?. Respirology 22, 628\u2013629 (2017).","journal-title":"Respirology"},{"key":"75597_CR42","doi-asserted-by":"crossref","unstructured":"Jones, P.W.\u00a0et al.\u00a0Minimal clinically important differences in pharmacological trials. Am. J. Respir. Crit. Care Med. 189, 250\u2013255 (2014).","DOI":"10.1164\/rccm.201310-1863PP"},{"key":"75597_CR43","doi-asserted-by":"crossref","unstructured":"Kon, S.S.\u00a0et al.\u00a0Minimum clinically important difference for the COPD assessment test: A prospective analysis. Lancet Respir. Med. 2, 195\u2013203 (2014).","DOI":"10.1016\/S2213-2600(14)70001-3"},{"key":"75597_CR44","doi-asserted-by":"crossref","unstructured":"Vainshelboim, B., Kramer, M. R., Izhakian, S., Lima, R. M. & Oliveira, J. Physical activity and exertional desaturation are associated with mortality in idiopathic pulmonary fibrosis.\u00a0J. Clin. Med. Res.\u00a05 (2016).","DOI":"10.3390\/jcm5080073"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75597-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75597-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75597-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:32:33Z","timestamp":1670365953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75597-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75597"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75597-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]},"assertion":[{"value":"24 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18633"}}